- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05474131
Pediatric Out-of-hospital Cardiopulmonary Arrest (Ped-CPA)
Pediatric Out-of-hospital Cardiopulmonary Arrest, Current Status of Out-of-hospital Management, Predictive Factors of Mortality, Physicians' Attitudes, Training Perspectives : a Multicentric Retrospective Study.
The objective of this observational and retrospective study is to determine the predictive factors of in-hospital mortality following an out-of-hospital cardiopulmonary arrest (CPA) in the population under 18 years old. Data are collected from telephone calls and medical regulation records processed by the health call center of 2 french departments between January 1, 2019, and March 15, 2022. The medical records of the included patients will also be reread in order to obtain the patient's status at 30 days after the CPA.
Detailed description:
The literature reports numerous works evaluating the epidemiological characteristics of pediatric out-of-hospital cardiorespiratory arrest. An improvement in survival has been reported in the case of resuscitation guided by the operator in medical regulation before the arrival of the emergency services. Indeed, the regulation phase at the 15 center in France is of fundamental importance. Recent evolutions, notably with the creation of specific call-taking professions, show the importance attached to improving practices.
The population concerned is characterized by children under 18 years of age, victims of an extra-hospital cardiorespiratory arrest. It is a retrospective study over three years and three months, multicentric, from the emergency service (SAMU) 57 and 69.
The primary endpoint was the all-cause mortality at thirty days of the admission.
The case report form (CRF) will collect the main aspects of telephone management at the 15 centers, out-of-hospital management by the emergency teams, and the personal characteristics of the emergency physicians and out-of-hospital responders (gender, age, family situation, etc.). The medical management in the emergency department and the first stages of in-hospital management will also be analyzed. The patients included who are still alive will receive a notification of non-objection by mail.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Metz, France, 57085
- CHR Metz-Thionville/Hopital de Mercy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- child under 17 years old
- and call for cardiac arrest or cardiac arrest detected on call
Exclusion Criteria:
- non-real cardiac arrest
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
death from any cause within thirty days of admission
Time Frame: at day 30
|
The vital status at Day 30 will be systematically sought.
|
at day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resuscitation in pre-hospital care during the listening of the sound tapes of the SAMU
Time Frame: at day 1
|
The resumption of a spontaneous cardiac activity will be sought during the listening of the sound tapes of the SAMU
|
at day 1
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Laure ABENSUR VUILLAUME, PhD, MD, CHR Metz Thionville Hopital de Mercy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-07Obs-CHRMT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Arrest
-
National Taiwan University HospitalEnrolling by invitationOut of Hospital Cardiac Arrest | Inhospital Cardiac ArrestTaiwan
-
Haseki Training and Research HospitalCompletedCardiac Arrest (CA) | Out of Hospital Cardiac ArrestTurkey
-
Lars Wiuff AndersenUniversity of AarhusRecruitingCardiac Arrest (CA)Denmark
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruiting
-
Medical University of GdanskActive, not recruitingCardiac Complications | Sudden Cardiac Arrest | Cardiac Arrest (CA) | Cardiac DiseasesPoland
-
Italian Resuscitation CouncilUnknownOut-Of-Hospital Cardiac Arrest | In-hospital Cardiac ArrestItaly
-
University Hospital, GhentRecruitingCardiac Arrest (CA) | Out-of-hospital Cardiac Arrest (OHCA) | Resuscitated Sudden Cardiac DeathBelgium
-
Emergency Medical Services, Capital Region, DenmarkOdense University Hospital; TrygFonden, Denmark; Aalborg University HospitalUnknownOut-Of-Hospital Cardiac Arrest | Pediatric Disorder | Cardiopulmonary ArrestDenmark
-
National Taiwan University HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
Università Vita-Salute San RaffaelePolitecnico di Milano; IRCCS Ospedale San Raffaele; Azienda Ospedaliera Universitaria... and other collaboratorsRecruitingCardiac Arrest | Out-Of-Hospital Cardiac ArrestItaly